Deep Multiple Instance Learning Model to Predict Outcome of Pancreatic Cancer Following Surgery
Caroline Truntzer, Dina Ouahbi, Titouan Huppé et al. · Biomedicines · 2024
Background/Objectives: Pancreatic ductal adenocarcinoma (PDAC) is a cancer with very poor prognosis despite early surgical management. To date, only clinical variables are used to predict outcome for decision-making about adjuvant therapy. We sought to generate a deep learning approach based on hematoxylin and eosin (H&E) or hematoxylin, eosin and saffron (HES) whole slides to predict patients’ outcome, compare these new entities with known molecular subtypes and question their biological significance; Methods: We used as a training set a retrospective private cohort of 206 patients treated by surgery for PDAC cancer and a validation cohort of 166 non-metastatic patients from The Cancer Genome Atlas (TCGA) PDAC project. We estimated a multi-instance learning survival model to predict relapse in the training set and evaluated its performance in the validation set. RNAseq and exome data from the TCGA PDAC database were used to describe the transcriptomic and genomic features associated with deep learning classification; Results: Based on the estimation of an attention-based multi-instance learning survival model, we identified two groups of patients with a distinct prognosis. There was a significant difference in progression-free survival (PFS) between these two groups in the training set (hazard ratio HR = 0.72 [0.54;0.96]; p = 0.03) and in the validation set (HR = 0.63 [0.42;0.94]; p = 0.01). Transcriptomic and genomic features revealed that the poor prognosis group was associated with a squamous phenotype. Conclusions: Our study demonstrates that deep learning could be used to predict PDAC prognosis and offer assistance in better choosing adjuvant treatment.
Cited by 3 works. doi:10.3390/biomedicines12122754 Open-access PDF
Authors
- Caroline Truntzer
- Dina Ouahbi
- Titouan Huppé
- David Rageot
- Alis Ilie
- Chloé Molimard
- Françoise Beltjens
- Anthony Bergeron
- Angélique Vienot
- Christophe Borg
- Franck Monnien
- Frédéric Bibeau
- Valentin Dérangère
- François Ghiringhelli
References
- Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
- Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
- Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
- STAR: ultrafast universal RNA-seq aligner
- Adjuvant Chemotherapy With Gemcitabine vs Observation in Patients Undergoing Curative-Intent Resection of Pancreatic Cancer
- Genomic analyses identify molecular subtypes of pancreatic cancer
- FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer
- A method for normalizing histology slides for quantitative analysis
- TCGAbiolinks: an R/Bioconductor package for integrative analysis of TCGA data
- Adjuvant Chemotherapy With Fluorouracil Plus Folinic Acid vs Gemcitabine Following Pancreatic Cancer Resection